Subcutaneous adipose tissue insulin resistance and lipolysis in patients with nonalcoholic steatohepatitis
Κύριοι συγγραφείς: | Armstrong, M, Hazlehurst, J, Hull, D, Borrows, S, Guo, K, Yu, J, Barton, D, Gaunt, P, Gough, S, Tomlinson, J, Newsome, P |
---|---|
Μορφή: | Conference item |
Έκδοση: |
2013
|
Παρόμοια τεκμήρια
Παρόμοια τεκμήρια
-
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis
ανά: Armstrong, M, κ.ά.
Έκδοση: (2014) -
Abdominal subcutaneous adipose tissue insulin resistance and lipolysis in patients with non-alcoholic steatohepatitis.
ανά: Armstrong, M, κ.ά.
Έκδοση: (2014) -
Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
ανά: Armstrong, M, κ.ά.
Έκδοση: (2013) -
Glucocorticoids fail to cause insulin resistance in human subcutaneous adipose tissue in vivo.
ανά: Hazlehurst, J, κ.ά.
Έκδοση: (2013) -
Orlistat for overweight subjects with nonalcoholic steatohepatitis.
ανά: Dowman, J, κ.ά.
Έκδοση: (2009)